1-117963816-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206996.4(SPAG17):c.6655A>C(p.Lys2219Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206996.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPAG17 | ENST00000336338.10 | c.6655A>C | p.Lys2219Gln | missense_variant | Exon 48 of 49 | 1 | NM_206996.4 | ENSP00000337804.5 | ||
WDR3 | ENST00000349139.6 | c.*4369T>G | 3_prime_UTR_variant | Exon 27 of 27 | 1 | NM_006784.3 | ENSP00000308179.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.6655A>C (p.K2219Q) alteration is located in exon 48 (coding exon 48) of the SPAG17 gene. This alteration results from a A to C substitution at nucleotide position 6655, causing the lysine (K) at amino acid position 2219 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.